ALVR106
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALVR106, covering 2024-06-06 to 2024-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant [Phase 1, Phase 2]